[Interventricular management of patients over the age of 75 with acute coronary syndromes without persistent ST

A Géhanne1, A Shayne, H Eltchaninoff

  • 1Département de cardiologie, centre cardiopneumologique CHU Rennes.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 13, 2005
PubMed

Insights

Interventional strategy for elderly patients with acute coronary syndromes (ACS) showed a low rate of major adverse events. Further randomized trials are needed to confirm these benefits in older populations.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Context:

  • Elderly patients (>75 years) admitted with acute coronary syndromes (ACS) without persistent ST elevation represent a vulnerable population.
  • Optimal management strategies for this demographic remain an area of active investigation.
  • Multicenter registry data provides insights into real-world outcomes.

Purpose:

  • To assess the outcomes of an interventional strategy in patients over 75 years old admitted with ACS.
  • To evaluate major cardiovascular adverse events (MACE) and complications in this elderly cohort.
  • To determine the feasibility and safety of coronary angiography and percutaneous coronary intervention in this age group.

Summary:

  • A multicenter registry included 126 patients (average age 79) with ACS, with 70% having poor prognostic factors.
  • Coronary angiography revealed significant multi-vessel disease in most patients; percutaneous coronary intervention was performed in 82 patients.
  • Hospital phase had 3 major cardiovascular complications; at 6 months, 8 (6.5%) MACE occurred, with 6 in the angioplasty group, including 5 deaths and 3 myocardial infarctions.

Impact:

  • The interventional strategy in elderly ACS patients demonstrated a low rate of major adverse events.
  • Findings suggest potential benefits of early revascularization in selected elderly ACS patients.
  • Results highlight the need for randomized controlled trials to definitively establish the efficacy of interventional approaches in this population.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...